Journal
CANCER RESEARCH
Volume 70, Issue 24, Pages 10192-10201Publisher
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-10-2429
Keywords
-
Categories
Funding
- National Institutes of Health [2-R01 DK37034, 1 R01 DK073336, 1 R01 DK070195]
- NIH [1P30 CA138313]
Ask authors/readers for more resources
Formation of the mitochondrial membrane potential (Delta psi) depends on flux of respiratory substrates, ATP, ADP, and Pi through voltage-dependent anion channels (VDAC). As tubulin promotes single-channel closure of VDAC, we hypothesized that tubulin is a dynamic regulator of Delta psi, which in cultured cancer cells was assessed by confocal microscopy of the potential-indicating fluorophore tetramethylrhodamine methylester (TMRM). Microtubule destabilizers, rotenone, colchicine, and nocodazole, and the microtubule stabilizer paclitaxel increased and decreased cellular free tubulin, respectively, and in parallel decreased and increased Delta psi. Protein kinase A (PKA) activation by cAMP analogues and glycogen synthase kinase 3 beta (GSK-3 beta) inhibition decreased Delta psi, whereas PKA inhibition hyperpolarized, consistent with reports that PKA and GSK-3 beta decrease and increase VDAC conductance, respectively. Plasma membrane potential assessed by DiBAC(4)(3) was not altered by any of the treatments. We propose that inhibition of VDAC by free tubulin limits mitochondrial metabolism in cancer cells. Cancer Res; 70(24); 10192-201. (C) 2010 AACR.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available